HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ximena Terra Selected Research

proanthocyanidin

6/2021Grape-Seed Proanthocyanidin Extract Reverts Obesity-Related Metabolic Derangements in Aged Female Rats.
1/2020Health-Promoting Properties of Proanthocyanidins for Intestinal Dysfunction.
12/2019Long-Lasting Effects of GSPE on Ileal GLP-1R Gene Expression Are Associated with a Hypomethylation of the GLP-1R Promoter in Female Wistar Rats.
4/2019Grape-Seed Proanthocyanidins are Able to Reverse Intestinal Dysfunction and Metabolic Endotoxemia Induced by a Cafeteria Diet in Wistar Rats.
12/2018The co-administration of proanthocyanidins and an obesogenic diet prevents the increase in intestinal permeability and metabolic endotoxemia derived to the diet.
3/2018Grape seed proanthocyanidins influence gut microbiota and enteroendocrine secretions in female rats.
6/2017A specific dose of grape seed-derived proanthocyanidins to inhibit body weight gain limits food intake and increases energy expenditure in rats.
1/2017Chronic supplementation with dietary proanthocyanidins protects from diet-induced intestinal alterations in obese rats.
1/2016Acutely administered grape-seed proanthocyanidin extract acts as a satiating agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ximena Terra Research Topics

Disease

13Obesity
03/2022 - 03/2009
11Inflammation (Inflammations)
01/2020 - 03/2009
8Body Weight (Weight, Body)
06/2022 - 04/2011
8Squamous Cell Carcinoma of Head and Neck
04/2022 - 03/2013
5Insulin Resistance
12/2017 - 04/2011
4Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2022 - 04/2011
4Neoplasms (Cancer)
05/2021 - 03/2013
4Non-alcoholic Fatty Liver Disease
01/2014 - 07/2010
3Carcinoma (Carcinomatosis)
01/2021 - 03/2013
3Endotoxemia
04/2019 - 12/2018
3Morbid Obesity
02/2013 - 12/2011
2Pneumonia (Pneumonitis)
03/2022 - 03/2021
2COVID-19
03/2022 - 03/2021
2Diabetes Mellitus
01/2020 - 11/2012
2Weight Loss (Weight Reduction)
11/2013 - 11/2012
1Lymphatic Metastasis
04/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2022
1Cytokine Release Syndrome
03/2022
1Allergic Rhinitis
01/2022
1Mitochondrial Diseases (Mitochondrial Disease)
04/2021
1Disease Progression
03/2021
1Respiratory Insufficiency (Respiratory Failure)
03/2021
1Ketosis
11/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020
1Hypertrophy
01/2019
1Weight Gain
01/2018
1Radiation Injuries (Radiation Sickness)
01/2015
1Anorexia Nervosa
12/2013
1Starvation
12/2013
1Metabolic Diseases (Metabolic Disease)
02/2013
1Fatty Liver
02/2013
1Necrosis
11/2012

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
04/2022 - 04/2011
9proanthocyanidinIBA
06/2021 - 01/2016
8Proanthocyanidins (Procyanidins)IBA
01/2019 - 03/2009
8Messenger RNA (mRNA)IBA
06/2017 - 01/2010
7CytokinesIBA
03/2022 - 03/2009
6Glucose (Dextrose)FDA LinkGeneric
05/2021 - 04/2011
5Insulin (Novolin)FDA Link
11/2020 - 04/2011
4Interleukin-6 (Interleukin 6)IBA
03/2022 - 11/2012
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 04/2011
3AdipokinesIBA
12/2013 - 03/2009
3procyanidinIBA
04/2011 - 03/2009
2ResistinIBA
03/2022 - 11/2012
2FlavonoidsIBA
12/2019 - 12/2016
2Peroxidase (Myeloperoxidase)IBA
01/2019 - 01/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 01/2017
2CarbohydratesIBA
12/2018 - 01/2017
2LeptinIBA
10/2016 - 11/2013
2Fatty Acids (Saturated Fatty Acids)IBA
10/2016 - 01/2012
2EnzymesIBA
01/2014 - 01/2013
2ImmunosorbentsIBA
01/2014 - 01/2013
2Nicotinamide PhosphoribosyltransferaseIBA
02/2013 - 11/2012
2C-Reactive ProteinIBA
11/2012 - 04/2011
1dimemorfan (AT 17)IBA
06/2022
1Neuropilin-2IBA
04/2022
1Semaphorins (Semaphorin)IBA
04/2022
1Interleukin-8 (Interleukin 8)IBA
03/2022
1Interleukin-15 (Interleukin 15)IBA
03/2022
1Circulating MicroRNAIBA
05/2021
1Tumor Biomarkers (Tumor Markers)IBA
05/2021
1MicroRNAs (MicroRNA)IBA
05/2021
1Succinate Dehydrogenase (Fumarate Reductase)IBA
04/2021
1Succinic Acid (Succinate)IBA
04/2021
1tocilizumab (atlizumab)FDA Link
03/2021
1CreatinineIBA
03/2021
1TroponinIBA
03/2021
1Alanine (L-Alanine)FDA Link
01/2021
1Aspartic Acid (Aspartate)FDA Link
01/2021
1Glucagon (Glukagon)FDA Link
11/2020
1Hormones (Hormone)IBA
01/2020
1Glucagon-Like Peptide 1 (GLP 1)IBA
12/2019
1Grape Seed ProanthocyanidinsIBA
04/2019
1Phenobarbital (Luminal)FDA Link
01/2019
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2019
1OvalbuminIBA
01/2019
1EndotoxinsIBA
01/2019
1Butyrates (Butyrate)IBA
01/2019
1LipidsIBA
01/2018
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2017
1Nonesterified Fatty Acids (NEFA)IBA
10/2016
1Triglycerides (Triacylglycerol)IBA
10/2016
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
07/2015
1prostacyclin synthetase (prostacyclin synthase)IBA
01/2015
1Proteins (Proteins, Gene)FDA Link
01/2015
1Epoprostenol (Prostacyclin)FDA LinkGeneric
01/2015
1RetinoidsIBA
01/2015
1Conditioned Culture MediaIBA
01/2015
1carboprostacyclinIBA
01/2015
1EndocannabinoidsIBA
01/2014
1CannabinoidsIBA
01/2014
1GhrelinIBA
11/2013
1NF-kappa B (NF-kB)IBA
03/2013
1Vitamin A (Retinol)FDA LinkGeneric
01/2013

Therapy/Procedure

4Radiotherapy
01/2021 - 03/2013
3Chemoradiotherapy
01/2021 - 03/2013
2Therapeutics
12/2016 - 01/2015
2Bariatric Surgery
11/2013 - 11/2012
1Neck Dissection (Radical Neck Dissection)
04/2022
1Artificial Respiration (Mechanical Ventilation)
03/2022